Association hopes to prep supply chain for one of its largest logistical challenges
The International Air Transport Association (IATA), which previously noted that month-on-month global demand for air cargo in September increased 3.7% over August numbers, recently released logistics supply chain guidance to help make sure that the air cargo industry is ready to support the handling, transportation and distribution of a Covid-19 vaccine.
Produced with the backing of various partners, such as the International Civil Aviation Organization (ICAO), International Federation of Freight Forwarders Associations (FIATA), International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Pan American Health Organization (PAHO), UK Civil Aviation Authority, World Bank, World Customs Organization (WCO) and World Trade Organization (WTO), IATA’s Guidance for Vaccine and Pharmaceutical Logistics and Distribution consists of myriad international standards and guidelines related to the transport of vaccines, being revised as frequently as information is made available.
The association, as reported by AviationPros, references several notable obstacles, including:
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In
October 30th 2024In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In
October 30th 2024In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.
485 Route 1 South,
Building F, Suite 210
Iselin, NJ 08830